AI assistant
Sending…
Sanara MedTech Inc. — Director's Dealing 2015
Jun 23, 2015
33339_dirs_2015-06-23_1a3172bd-4815-433d-8eb0-aac86dff1c96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2015-05-18
Reporting Person: HOWELL S ODEN JR (Director, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Series C Preferred Stock | 16535 | Direct |
| Series C Preferred Stock | 2959 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant | $0.15 | 2017-07-23 | Common Stock (250000) | Direct | |
| Convertible Secured Subordinated Promissory Note | $0.7 | 2018-06-15 | Series C Preferred Stock () | Indirect |
Footnotes
F1: This warrant may be exercised, in whole or in part, on or prior to July 23, 2017.
F2: This Note provides that the remaining balance may be converted, at the option of the Lender, into shares of preferred stock at any time prior to either (i) the third anniversary of the date of the Note (such date being June 15, 2018), or (ii) the occurrence of an Event of Default.
More from Sanara MedTech Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Major Shareholding Notification
2026
Apr 14
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 23